DK1066029T3 - Suspension of orally active agent - Google Patents

Suspension of orally active agent

Info

Publication number
DK1066029T3
DK1066029T3 DK99913291T DK99913291T DK1066029T3 DK 1066029 T3 DK1066029 T3 DK 1066029T3 DK 99913291 T DK99913291 T DK 99913291T DK 99913291 T DK99913291 T DK 99913291T DK 1066029 T3 DK1066029 T3 DK 1066029T3
Authority
DK
Denmark
Prior art keywords
suspension
active agent
orally active
orally
agent
Prior art date
Application number
DK99913291T
Other languages
Danish (da)
Inventor
Dietrich Tuerck
Veit Schmelmer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1066029T3 publication Critical patent/DK1066029T3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK99913291T 1998-03-27 1999-03-23 Suspension of orally active agent DK1066029T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (en) 1998-03-27 1998-03-27 Peroral drug suspension
PCT/EP1999/001948 WO1999049845A1 (en) 1998-03-27 1999-03-23 Peroral active agent suspension

Publications (1)

Publication Number Publication Date
DK1066029T3 true DK1066029T3 (en) 2003-01-27

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99913291T DK1066029T3 (en) 1998-03-27 1999-03-23 Suspension of orally active agent

Country Status (26)

Country Link
EP (2) EP0945131A1 (en)
JP (1) JP3323189B2 (en)
KR (1) KR100587208B1 (en)
CN (1) CN1150888C (en)
AR (1) AR016196A1 (en)
AT (1) ATE225648T1 (en)
AU (1) AU762464B2 (en)
BR (1) BR9909189A (en)
CA (1) CA2326048C (en)
CO (1) CO5070601A1 (en)
DE (1) DE59903023D1 (en)
DK (1) DK1066029T3 (en)
ES (1) ES2184428T3 (en)
HK (1) HK1034184A1 (en)
HU (1) HU228474B1 (en)
IL (1) IL137479A (en)
MY (1) MY124599A (en)
NO (1) NO321401B1 (en)
NZ (1) NZ507610A (en)
PL (1) PL192969B1 (en)
PT (1) PT1066029E (en)
TR (1) TR200002772T2 (en)
TW (1) TWI232759B (en)
UY (1) UY25443A1 (en)
WO (1) WO1999049845A1 (en)
ZA (1) ZA200003951B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
PL1824493T3 (en) * 2004-12-06 2009-01-30 Janssen Pharmaceutica Nv Oral suspension comprising meloxicam
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
US9101529B2 (en) 2009-10-12 2015-08-11 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
AU2011225810B2 (en) * 2010-03-10 2014-11-06 Lupin Limited Rifaximin ready-to-use suspension
CA2959931A1 (en) * 2010-03-19 2011-09-22 Boston Biomedical, Inc. Naphthofuran compounds and compositions for targeting cancer stem cells
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
CN104854411B (en) * 2012-12-19 2017-06-13 三菱电机株式会社 Air conditioner
MX2017013715A (en) 2015-04-28 2018-03-02 Mars Inc Process of preparing a sterilized wet pet food product.
KR102145022B1 (en) * 2018-08-14 2020-08-14 동아제약 주식회사 Suspension composition and dosage form of ibuprofen
CN112044605B (en) * 2019-06-06 2022-06-21 钟志勇 Titanium selection medicament and titanium selection method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (en) * 1984-10-22 1988-11-16 Chiesi Farma Spa AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (en) * 1992-03-10 1999-02-24 エスエス製薬株式会社 Planoprofen suspension syrup
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
EP1066029A1 (en) 2001-01-10
HUP0102036A3 (en) 2002-12-28
DE59903023D1 (en) 2002-11-14
HUP0102036A2 (en) 2002-03-28
ES2184428T3 (en) 2003-04-01
JP2002509875A (en) 2002-04-02
CA2326048A1 (en) 1999-10-07
MY124599A (en) 2006-06-30
TR200002772T2 (en) 2000-12-21
AU3147099A (en) 1999-10-18
PT1066029E (en) 2003-02-28
HU228474B1 (en) 2013-03-28
NZ507610A (en) 2003-08-29
TWI232759B (en) 2005-05-21
AR016196A1 (en) 2001-06-20
CO5070601A1 (en) 2001-08-28
HK1034184A1 (en) 2001-10-19
UY25443A1 (en) 1999-11-17
NO20004822D0 (en) 2000-09-26
NO20004822L (en) 2000-11-23
EP1066029B1 (en) 2002-10-09
PL342345A1 (en) 2001-06-04
BR9909189A (en) 2000-12-05
CN1150888C (en) 2004-05-26
PL192969B1 (en) 2006-12-29
ATE225648T1 (en) 2002-10-15
AU762464B2 (en) 2003-06-26
WO1999049845A1 (en) 1999-10-07
IL137479A0 (en) 2001-07-24
IL137479A (en) 2005-09-25
EP0945131A1 (en) 1999-09-29
JP3323189B2 (en) 2002-09-09
ZA200003951B (en) 2002-01-18
CA2326048C (en) 2008-08-12
NO321401B1 (en) 2006-05-08
KR20010042197A (en) 2001-05-25
CN1295462A (en) 2001-05-16
KR100587208B1 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
DK1066029T3 (en) Suspension of orally active agent
FI981614A (en) Evacuation of bearing condition
ID27092A (en) MAKING OF ANHYDRIDAL FTALATES
IS2325B (en) Microplated formulations of eplerone
DK1073416T3 (en) Use of NO as an anti-inflammatory agent
DE60024115D1 (en) PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES
AR028567A1 (en) NEW DERIVATIVES OF FENIL-PROPARGILETER
DE69908638D1 (en) Lithographic Contact Structures
DK199801716A (en) Headset
EE200100395A (en) Potassium salt of (S) -omeprazole
NO20004949L (en) sulfonamide
NO20020222L (en) Orally active androgens
ID28208A (en) CONSTRUCTION OF FLOATING HOLDERS
IS5772A (en) Phthalazine derivatives of phosphodiesterase4 inhibitors
DK1210085T3 (en) Pharmaceutical solutions of levosimendan
DE69911152D1 (en) Symmetrical amplifier
FR2776660B1 (en) DIAZEPINO-INDOLES OF PHOSPHODIESTERASES IV
ID24677A (en) COMBINATION OF FUNICIDAL ACTIVE COMPOUNDS
ID28032A (en) TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2
DK1155050T3 (en) Preparation of polyolefin
DE69907845D1 (en) Sulfonamide derivatives
NO20013810D0 (en) Use of cholesterol lowering agent
ID28397A (en) STRUCTURE OF STABILITY TOOLS
DK1102747T3 (en) Crystal forms of osenetant
EE200100017A (en) New salts of N-tert-butylhydroxylamine